Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-00299804 in recurrent/metastatic head and neck squamous cell carcinoma
NCT00768664Phase 2Completed
- Sponsor
- Pfizer
- Start
- Nov 2008
- Primary completion
- May 2010
- Modality
- Fragment-Derived Small Molecules, Allosteric Modulators, Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dacomitinib in head and neck squamous cell carcinoma (HNSCC), sponsored by Pfizer. Started Nov 2008; status: completed.
02
Drugs
dacomitinib
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00768664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00768664.